Comparing the effectiveness of biosimilar filgrastim (Nivestim®) versus original filgrastim (Neupogen®) for stem cell mobilization in adult and pediatric healthy donors
Journal of Oncology Pharmacy Practice
Published online on June 26, 2023
Abstract
Journal of Oncology Pharmacy Practice, Volume 32, Issue 3, Page 525-528, April 2026.
IntroductionFilgrastim is used for the mobilization of stem cells in healthy donors. Though several biosimilar filgrastim products have been approved, there is limited literature evaluating biosimilar products for stem cell mobilization. Therefore, we ...
IntroductionFilgrastim is used for the mobilization of stem cells in healthy donors. Though several biosimilar filgrastim products have been approved, there is limited literature evaluating biosimilar products for stem cell mobilization. Therefore, we ...